Absence of progression as assessed by response evaluation criteria in solid tumors predicts survival in advanced GI stromal tumors treated with imatinib mesylate: the intergroup EORTC-ISG-AGITG phase III trial
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Martine van Glabbeke Paolo Giovanni Casali Axel Le Cesne Pancras C.W. Hogendoorn Jean-Yves Blay Peter Reichardt Raf Sciot Jaap Verweij Serge Leyvraz Rolf D Issels Ian Judson Patrick Schöffski |
| Publication date | July 20, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |